tradingkey.logo

iSpecimen Inc

ISPC
0.388USD
+0.007+1.89%
收盤 12/24, 13:00美東報價延遲15分鐘
3.79M總市值
虧損本益比TTM

iSpecimen Inc

0.388
+0.007+1.89%

關於 iSpecimen Inc 公司

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

iSpecimen Inc簡介

公司代碼ISPC
公司名稱iSpecimen Inc
上市日期Jun 17, 2021
CEOField (Katharyn)
員工數量24
證券類型Ordinary Share
年結日Jun 17
公司地址8 Cabot Road
城市WOBURN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編08101
電話17813016700
網址https://www.ispecimen.com/
公司代碼ISPC
上市日期Jun 17, 2021
CEOField (Katharyn)

iSpecimen Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Specimens – contracts with customers
671.69K
94.19%
Shipping and other
41.44K
5.81%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Specimens – contracts with customers
671.69K
94.19%
Shipping and other
41.44K
5.81%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
其他
96.62%
持股股東
持股股東
佔比
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
其他
96.62%
股東類型
持股股東
佔比
Hedge Fund
1.59%
Research Firm
0.86%
Investment Advisor
0.63%
Corporation
0.43%
Investment Advisor/Hedge Fund
0.43%
Individual Investor
0.26%
其他
95.80%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
26
96.86K
1.75%
-11.14K
2025Q2
31
133.51K
3.29%
-45.19K
2025Q1
37
201.48K
8.20%
-43.25K
2024Q4
37
175.36K
18.22%
-42.87K
2024Q3
38
178.54K
25.34%
-4.65K
2024Q2
37
155.60K
21.84%
-23.10K
2024Q1
38
168.39K
35.92%
-17.71K
2023Q4
42
174.70K
38.71%
-30.54K
2023Q3
48
208.00K
46.18%
-25.86K
2023Q2
48
208.72K
46.34%
-34.91K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Virtu Americas LLC
--
0%
-2.10K
-100.00%
Sep 30, 2024
OBF Investments LLC
42.10K
0.76%
+1.00
+0.00%
Dec 31, 2024
Geode Capital Management, L.L.C.
14.81K
0.27%
+4.08K
+37.96%
Jun 30, 2025
The Vanguard Group, Inc.
1.24K
0.02%
--
--
Aug 31, 2025
Wolf (James G)
25.25K
0.46%
-14.29K
-36.14%
Jun 03, 2024
BlackRock Institutional Trust Company, N.A.
2.83K
0.05%
--
--
Jun 30, 2025
Tower Research Capital LLC
6.19K
0.11%
+3.21K
+107.51%
Jun 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
公告日期
類型
比率
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1

常見問題

iSpecimen Inc的前五大股東是誰?

iSpecimen Inc的前五大股東如下:
Virtu Americas LLC
持有股份:0.00
佔總股份比例:0.00%。
OBF Investments LLC
持有股份:42.10K
佔總股份比例:0.76%。
Geode Capital Management, L.L.C.
持有股份:14.81K
佔總股份比例:0.27%。
The Vanguard Group, Inc.
持有股份:1.24K
佔總股份比例:0.02%。
Wolf (James G)
持有股份:25.25K
佔總股份比例:0.46%。

iSpecimen Inc的前三大股東類型是什麼?

iSpecimen Inc 的前三大股東類型分別是:
Renaissance Technologies LLC
Virtu Americas LLC
OBF Investments LLC

有多少機構持有iSpecimen Inc(ISPC)的股份?

截至2025Q3,共有26家機構持有iSpecimen Inc的股份,合計持有的股份價值約為96.86K,占公司總股份的1.75% 。與2025Q2相比,機構持股有所增加,增幅為-1.54%。

哪個業務部門對iSpecimen Inc的收入貢獻最大?

在FY2025Q2,Specimens – contracts with customers業務部門對iSpecimen Inc的收入貢獻最大,創收671.69K,占總收入的94.19% 。
KeyAI